THE IMPACT OF UNCONTROLLED HYPERTENSION ON CARDIOVASCULAR RISK IN PATIENTS WITH METABOLIC SYNDROME

被引:0
作者
Tsounis, D. [1 ]
Brellas, N. [1 ]
Stamos, G. [1 ]
Laschos, V. [1 ]
Voutsela, D. [1 ]
Platoyiannis, D. [1 ]
机构
[1] Gen Hosp Trikala, Dept Cardiol, Trikala, Greece
关键词
D O I
10.1097/01.hjh.0000379652.78438.1f
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:E483 / E483
页数:1
相关论文
共 50 条
  • [31] Uncontrolled hypertension: A neglected risk in patients with NAFLD
    Kasper, Philipp
    Martin, Anna
    zu Schwabedissen, Albrecht Meyer
    Scherdel, Julia
    Lang, Sonja
    Goeser, Tobias
    Demir, Muenevver
    Steffen, Hans-Michael
    JOURNAL OF INTERNAL MEDICINE, 2022, 292 (01) : 162 - 164
  • [32] Impact of inflammatory mavkevs on cardiovascular mortality in patients with metabolic syndrome
    Espinola-Klein, Christine
    Rupprecht, Hans J.
    Bickel, Christoph
    Lackner, Karl
    Zotz, Sabine Genth
    Post, Felix
    Munzel, Thomas
    Blankenberg, Stefan
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2008, 15 (03): : 278 - 284
  • [33] Prevalence of metabolic syndrome in patients with essential hypertension - impact of gender
    Lakowska, Anna
    Chrostowska, Marzena
    Szyndler, Anna
    Smialek, Katarzyna
    Szczech, Radoslaw
    Zdrojewski, Tomasz
    Narkiewicz, Krzysztof
    ARTERIAL HYPERTENSION, 2005, 9 (06): : 458 - 462
  • [34] Surgical risk in patients with metabolic syndrome: Focus on lipids and hypertension
    Watson K.
    Current Cardiology Reports, 2006, 8 (6) : 433 - 438
  • [35] Cardiovascular risk and metabolic syndrome in patients with obstructive sleep apnea
    Tkacova, R.
    Dorkova, Z.
    Molcanyiova, A.
    Radikova, Z.
    Klimes, I.
    Tkac, I.
    DIABETOLOGIA, 2007, 50 : S503 - S503
  • [36] Metabolic syndrome, cardiovascular risk and antipsychotic treatment in schizophrenic patients
    Castano, J.
    Diaz, B.
    Garnier, C.
    Sanchis, R.
    Horta, A.
    Navarro, A.
    Navines, R.
    Martin, L. M.
    Bulbena, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S419 - S419
  • [37] Metabolic syndrome and cardiovascular risk profile in patients with myocardial infarction
    Levantesi, G
    Macchia, A
    Maggioni, AP
    Franzosi, MG
    Tavazzi, L
    Tognoni, G
    Valagussa, F
    Marchioli, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 475A - 475A
  • [38] Pharmacologic Therapy for Cardiovascular Risk Reduction in Patients with the Metabolic Syndrome
    Gouni-Berthold, Ioanna
    Berthold, Heiner K.
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (31) : 5025 - 5038
  • [39] Metabolic Syndrome and Cardiovascular Risk in Elderly Treated Hypertensive Patients
    Pierdomenico, Sante D.
    Pierdomenico, Anna M.
    Di Tommaso, Roberta
    Coccina, Francesca
    Di Carlo, Silvio
    Cuccurullo, Franco
    Porreca, Ettore
    AMERICAN JOURNAL OF HYPERTENSION, 2016, 29 (03) : 365 - 371
  • [40] Prevalence of metabolic syndrome and cardiovascular risk in patients with schizoaffective disorders
    Benabarre, A.
    Garcia-Portilla, M. P.
    Livianos, L.
    Mesa, F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S323 - S324